EUVIMEDEUVIMED entdecken
Crossref

A novel LncRNA TUG1/miR-30d/e-3p/SNAI2 ceRNA axis drives dermal fibrosis in systemic sclerosis via direct transcriptional activation of COL1A1

Ruixuan Zhu, Yangfan Xiao, Licong Liu, Ke Chai, Hongyan Gong, Yi Wei, Ziqian Tang, Zehong Song, Jiani Liu, Yaqian Shi, Zhuotong Zeng, Rong Xiao und 1 weitere

International Immunopharmacology · 2026

DOI: 10.1016/j.intimp.2026.117232 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026. Verfasst von Ruixuan Zhu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Second Xiangya Hospital, Central South University, Changsha, Hunan, China; Clinical Medical Research Center of Major Skin …. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Scleroderma, Systemic, MicroRNAs, Snail Family Transcription Factors. Die Arbeit nennt 57 Literaturangaben. Gefördert von: Hunan Provincial Natural Science Foundation, Fundamental Research Funds for Central Universities of the Central South University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic sclerosis (SSc) is a severe autoimmune disease characterized by progressive dermal fibrosis, aberrant fibroblast activation, and excessive collagen deposition. Although noncoding RNA-mediated regulation has been increasingly implicated in fibrotic diseases, the role of the long noncoding RNA taurine-upregulated gene 1 (TUG1) in SSc-associated skin fibrosis remains unclear. In this study, we investigated the function and mechanism of TUG1 in primary dermal fibroblasts isolated from lesional skin of patients with SSc and in a bleomycin-induced mouse model of dermal fibrosis. TUG1 expression was significantly increased in SSc dermal fibroblasts. Functional assays showed that TUG1 promoted fibroblast proliferation, migration, and COL1A1 expression, whereas TUG1 silencing attenuated these profibrotic phenotypes. Mechanistically, TUG1 acted as a competing endogenous RNA by sponging miR-30d-3p and miR-30e-3p, thereby relieving their repression of the transcription factor SNAI2. SNAI2 directly bound to the COL1A1 promoter and activated its transcription. In vivo, Tug1 knockdown alleviated bleomycin-induced dermal fibrosis, increased miR-30d-3p/miR-30e-3p levels, and reduced SNAI2 expression and collagen deposition. These findings identify the TUG1-miR-30d-3p/miR-30e-3p-SNAI2-COL1A1 axis as a potential therapeutic target in SSc skin fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingScleroderma, SystemicMicroRNAsSnail Family Transcription FactorsCollagen Type ISkinAnimalsHumansFibrosisCollagen Type I, alpha 1 ChainFibroblastsBleomycinMiceRNA, Competitive EndogenousTranscriptional ActivationDisease Models, AnimalCells, CulturedMaleMice, Inbred C57BL

Stichwörter der Autor:innen

Competing endogenous RNADermal fibrosisSNAI2Systemic sclerosisTUG1miR-30 family

Substanzen

RNA, Long NoncodingMicroRNAsSnail Family Transcription FactorsCollagen Type ICollagen Type I, alpha 1 ChainBleomycinRNA, Competitive EndogenousTUG1 long noncoding RNA, humanMirn30d microRNA, mouselong non-coding RNA TUG1, mouse

Autor:innen und Institutionen

  • Department of Dermatology, Second Xiangya Hospital, Central South University, Changsha, Hunan, China; Clinical Medical Research Center of Major Skin Diseases and Skin Health of Hunan Province, Changsha, China; Clinical…
  • Clinical Medical Research Center for Systemic Autoimmune Diseases in Hunan Province, China; Department of Gynaecology and Obstetrics, the Second Xiangya Hospital of Central South University, Changsha, Hunan, China; Clin…
  • Clinical Medical Research Center for Systemic Autoimmune Diseases in Hunan Province, China; Department of Medical Genetics, Second Xiangya Hospita, Central South University, Changsha, Hunan, China. Electronic address: p…

Förderung

  • Hunan Provincial Natural Science Foundation
  • Fundamental Research Funds for Central Universities of the Central South University
  • National Natural Science Foundation of China

Zitieren

APA

Zhu, R., Xiao, Y., Liu, L., Chai, K., Gong, H., Wei, Y., Tang, Z., Song, Z., Liu, J., Shi, Y., Zeng, Z., Xiao, R., & Pi, Z. (2026). A novel LncRNA TUG1/miR-30d/e-3p/SNAI2 ceRNA axis drives dermal fibrosis in systemic sclerosis via direct transcriptional activation of COL1A1. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117232

Vancouver

Zhu R, Xiao Y, Liu L, Chai K, Gong H, Wei Y, et al. A novel LncRNA TUG1/miR-30d/e-3p/SNAI2 ceRNA axis drives dermal fibrosis in systemic sclerosis via direct transcriptional activation of COL1A1. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2026.117232

BibTeX
@article{Zhu2026,
  author = {Zhu, Ruixuan and Xiao, Yangfan and Liu, Licong and Chai, Ke and Gong, Hongyan and Wei, Yi and Tang, Ziqian and Song, Zehong and Liu, Jiani and Shi, Yaqian and Zeng, Zhuotong and Xiao, Rong and Pi, Zixin},
  title = {A novel LncRNA TUG1/miR-30d/e-3p/SNAI2 ceRNA axis drives dermal fibrosis in systemic sclerosis via direct transcriptional activation of COL1A1},
  journal = {International Immunopharmacology},
  year = {2026},
  doi = {10.1016/j.intimp.2026.117232}
}
Kostenlos starten →